Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 7, Pages e1178421
Publisher
Informa UK Limited
Online
2016-04-30
DOI
10.1080/2162402x.2016.1178421
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Innate immune function after breast, lung, and colorectal cancer surgery
- (2015) Maria F. Ramirez et al. JOURNAL OF SURGICAL RESEARCH
- Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery
- (2015) Chandan Verma et al. Journal of Translational Medicine
- Effect of Surgery on Pancreatic Tumor-Dependent Lymphocyte Asset
- (2015) Francesco Iannone et al. PANCREAS
- Immune signature of tumor infiltrating immune cells in renal cancer
- (2015) Katharina Geissler et al. OncoImmunology
- Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients
- (2015) M Christina Cox et al. OncoImmunology
- Natural Killer Cells Are Essential for the Ability of BRAF Inhibitors to Control BRAFV600E-Mutant Metastatic Melanoma
- (2014) L. Ferrari de Andrade et al. CANCER RESEARCH
- NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention
- (2014) Petra U. Prinz et al. INTERNATIONAL JOURNAL OF CANCER
- CD8+T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors
- (2014) Jiemiao Hu et al. Molecular Cancer
- The impact of ageing on natural killer cell function and potential consequences for health in older adults
- (2013) Jon Hazeldine et al. AGEING RESEARCH REVIEWS
- Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
- (2013) S. Rusakiewicz et al. CANCER RESEARCH
- Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
- (2013) R. Remark et al. CLINICAL CANCER RESEARCH
- Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer
- (2013) Yun-Peng Peng et al. Journal of Translational Medicine
- Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages
- (2013) Giulia Fregni et al. PLoS One
- Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease
- (2013) Carolyn M. Nielsen et al. Frontiers in Immunology
- Monitoring NK cell activity in patients with hematological malignancies
- (2013) Sébastien Viel et al. OncoImmunology
- Cancer immunoediting by the innate immune system in the absence of adaptive immunity
- (2012) Timothy O’Sullivan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- High DGK- and Disabled MAPK Pathways Cause Dysfunction of Human Tumor-Infiltrating CD8+ T Cells That Is Reversible by Pharmacologic Intervention
- (2012) P. U. Prinz et al. JOURNAL OF IMMUNOLOGY
- Natural killer cells in non-hematopoietic malignancies
- (2012) Mélanie Desbois et al. Frontiers in Immunology
- Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands
- (2011) Beatriz Sanchez-Correa et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Unique Functional Status of Natural Killer Cells in Metastatic Stage IV Melanoma Patients and Its Modulation by Chemotherapy
- (2011) G. Fregni et al. CLINICAL CANCER RESEARCH
- Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
- (2011) M. R. Parkhurst et al. CLINICAL CANCER RESEARCH
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging
- (2011) Judith Eckl et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years
- (2010) N. Penel et al. ANNALS OF ONCOLOGY
- Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database
- (2010) A. Italiano et al. ANNALS OF ONCOLOGY
- Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) P. G. Casali et al. ANNALS OF ONCOLOGY
- CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
- (2010) S. Lopez-Verges et al. BLOOD
- Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity
- (2010) C. J. Sanchez et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-β1) in Patients with Gastric Cancer
- (2010) Andrzej Szkaradkiewicz et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- A Human NK Cell Activation/Inhibition Threshold Allows Small Changes in the Target Cell Surface Phenotype To Dramatically Alter Susceptibility to NK Cells
- (2010) T. D. Holmes et al. JOURNAL OF IMMUNOLOGY
- NKG2D Initiates Caspase-Mediated CD3 Degradation and Lymphocyte Receptor Impairments Associated with Human Cancer and Autoimmune Disease
- (2010) N. Hanaoka et al. JOURNAL OF IMMUNOLOGY
- The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients
- (2010) Katarina Mirjačić Martinović et al. JOURNAL OF SURGICAL RESEARCH
- Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
- (2010) Rolf D Issels et al. LANCET ONCOLOGY
- Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions
- (2009) Trinidad Garcia-Iglesias et al. BMC CANCER
- Natural Killer Cell IFN- Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients
- (2009) C. Menard et al. CANCER RESEARCH
- CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A
- (2009) D N Eissens et al. LEUKEMIA
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression
- (2008) P. K. Chattopadhyay et al. JOURNAL OF LEUKOCYTE BIOLOGY
- NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
- (2008) Dirk H.J. Verhoeven et al. MOLECULAR IMMUNOLOGY
- NKG2D ligands in tumor immunity
- (2008) N Nausch et al. ONCOGENE
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More